Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adartrel 500microgram tablets
0409010H0BCAAAH
|
Adartrel | Ropinirole hydrochloride | Central Nervous System | 1,222 |
|
Colecalciferol 10,000unit tablets
0906040G0AACQCQ
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 1,219 |
|
SenSura Soft Seal convex ileo bag with dual filter, Hide-Away outlet and split cover, maxi 15-43mm
23601006342
|
SenSura Soft Seal convex ileo bag with dual filter, Hide-Away outlet and split cover, maxi 15-43mm | Ileostomy Bags | Stoma Appliances | 1,219 |
|
Fresubin Energy Fibre liquid (6 flavours)
0913011L0BCAAAA
|
Fresubin RtS 1.5 - 1.6 kcal/ml milkshake with fibre | RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011) | Nutrition and Blood | 1,218 |
|
Piracetam 1.2g tablets
0409030P0AAACAC
|
Piracetam | Piracetam | Central Nervous System | 1,218 |
|
Progesterone 200mg pessaries
0604012S0AAAEAE
|
Progesterone | Progesterone | Endocrine System | 1,218 |
|
Seroquel XL 50mg tablets
0402010ABBBAHAV
|
Seroquel | Quetiapine | Central Nervous System | 1,216 |
|
Diazepam 2mg/5ml oral suspension
0401020K0AACICI
|
Diazepam | Diazepam | Central Nervous System | 1,215 |
|
Fortijuce Starter Pack liquid
0913011M0BEAAAA
|
Fortijuce ready to serve 1.5 kcal/ml juice style | Ready to serve 1.5 kcal/ml juice style (0913011) | Nutrition and Blood | 1,215 |
|
Jobst for Men Explore class 1 (18-21mmHg) below knee closed toe
21270001887
|
Jobst for Men Explore class 1 (18-21mmHg) below knee closed toe | Lymphoedema Garments | Appliances | 1,215 |
|
Omnitrope SurePal 15 15mg/1.5ml inj cartridges
0605010S0BHAFBU
|
Omnitrope | Somatropin | Endocrine System | 1,215 |
|
Phyllocontin Forte Continus 350mg tablets
0301030C0BCABAC
|
Phyllocontin | Aminophylline hydrate | Respiratory System | 1,215 |
|
Folysil all silicone open ended catheter male 12Ch-18Ch
21020000860
|
Folysil all silicone open ended catheter male 12Ch-18Ch | Catheters | Appliances | 1,214 |
|
SenSura ileostomy bag with dual filter and Hide-Away outlet, maxi 10-65/76mm
23601006332
|
SenSura ileostomy bag with dual filter and Hide-Away outlet, maxi 10-65/76mm | Ileostomy Bags | Stoma Appliances | 1,214 |
|
Ubidecarenone 100mg capsules
091102000AABABA
|
Generic compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | 1,214 |
|
NiQuitin Clear 14mg patches
0410020B0BDAEAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,213 |
|
OpSite Plus dressing 6.5cm x 5cm
20030100248
|
OpSite Plus dressing 6.5cm x 5cm | Wound Management & Other Dressings | Dressings | 1,213 |
|
Kelo-cote gel
20031400021
|
Kelo-cote gel | Wound Management & Other Dressings | Dressings | 1,211 |
|
Xupad dressing pad 20cm x 20cm
20030100451
|
Xupad dressing pad 20cm x 20cm | Wound Management & Other Dressings | Dressings | 1,211 |
|
Bupeaze 70micrograms/hour transdermal patches
0407020B0BIACAG
|
Bupeaze | Buprenorphine | Central Nervous System | 1,210 |
|
Episenta 150mg modified-release capsules
0408010W0BIABBQ
|
Episenta | Sodium valproate | Central Nervous System | 1,210 |
|
VIZhyal 0.4% eye drops preservative free
21300000314
|
VIZhyal 0.4% eye drops preservative free | Eye Products | Appliances | 1,210 |
|
Vimpat 100mg tablets
0408010AHBBABAB
|
Vimpat | Lacosamide | Central Nervous System | 1,209 |
|
Haloperidol decanoate 100mg/1ml inj ampoules
0402020T0AAABAB
|
Haloperidol decanoate | Haloperidol decanoate | Central Nervous System | 1,208 |
|
Mediven Elegance class 2 (23-32mmHg) below knee closed toe
21270000477
|
Mediven Elegance class 2 (23-32mmHg) below knee closed toe | Lymphoedema Garments | Appliances | 1,208 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.